Statera Biopharma, Inc. Quarterly Debt-to-equity in % from Q3 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Statera Biopharma, Inc. quarterly Debt-to-equity history and growth rate from Q3 2012 to Q3 2022.
  • Statera Biopharma, Inc. Debt-to-equity for the quarter ending September 30, 2022 was -385 %, a 1268% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 -385 -418 -1268% Sep 30, 2022
Q2 2022 131 +83.9 +176% Jun 30, 2022
Q1 2022 79.8 -199 -71.3% Mar 31, 2022
Q4 2021 52.4 +116 Dec 31, 2021
Q3 2021 33 +60.9 Sep 30, 2021
Q2 2021 47.6 +73.7 Jun 30, 2021
Q1 2021 279 +304 Mar 31, 2021
Q4 2020 -63.5 -35.1 -124% Dec 31, 2020
Q3 2020 -27.9 +6.47 +18.8% Sep 30, 2020
Q2 2020 -26.2 +32.4 +55.3% Jun 30, 2020
Q1 2020 -25.1 +90.5 +78.3% Mar 31, 2020
Q4 2019 -28.4 +477 +94.4% Dec 31, 2019
Q3 2019 -34.4 -363 -110% Sep 30, 2019
Q2 2019 -58.6 -184 -147% Jun 30, 2019
Q1 2019 -116 -196 -244% Mar 31, 2019
Q4 2018 -505 -564 -957% Dec 31, 2018
Q3 2018 328 +280 +578% Sep 30, 2018
Q2 2018 125 +85.1 +211% Jun 30, 2018
Q1 2018 80.4 +35.9 +80.7% Mar 31, 2018
Q4 2017 58.9 +13 +28.2% Dec 31, 2017
Q3 2017 48.4 -2.07 -4.1% Sep 30, 2017
Q2 2017 40.4 -27.2 -40.2% Jun 30, 2017
Q1 2017 44.5 -121 -73.1% Mar 31, 2017
Q4 2016 46 -757 -94.3% Dec 31, 2016
Q3 2016 50.5 +721 Sep 30, 2016
Q2 2016 67.5 +221 Jun 30, 2016
Q1 2016 165 +325 Mar 31, 2016
Q4 2015 803 +962 Dec 31, 2015
Q3 2015 -671 -535 -395% Sep 30, 2015
Q2 2015 -153 +12.6 +7.58% Jun 30, 2015
Q1 2015 -160 +18.2 +10.2% Mar 31, 2015
Q4 2014 -158 +48.3 +23.4% Dec 31, 2014
Q3 2014 -136 +334 +71.1% Sep 30, 2014
Q2 2014 -166 +304 +64.7% Jun 30, 2014
Q1 2014 -178 +934 +84% Mar 31, 2014
Q4 2013 -207 -1.4K -117% Dec 31, 2013
Q3 2013 -469 -1.13K -171% Sep 30, 2013
Q2 2013 -470 Jun 30, 2013
Q1 2013 -1.11K Mar 31, 2013
Q4 2012 1.2K Dec 31, 2012
Q3 2012 657 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.